FDA Approved: TERBUTALINE SULFATE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for terbutaline sulfate, establishing a generic version of this bronchodilator.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Terbutaline sulfate (terbutaline sulfate)

Snippet

ORIG AP for TERBUTALINE SULFATE (TERBUTALINE SULFATE)